Severe cutaneous adverse drugs reactions associated with the use of oxicams: a case/non case study from the World Health Organization adverse drug reaction database

被引：0
|
作者：
Clarivet, B. [1 ]
Bres, V. [1 ]
Philibert, C. [1 ]
Trouilleux, C. [1 ]
Mathieu, O. [2 ]
Hillaire-Buys, D. [1 ]
Faillie, J. L. [1 ]
机构：
[1] Montpellier Univ Hosp, Dept Med Pharmacol & Toxicol, Pharmacovigilance Reg Ctr, Montpellier, France
[2] Montpellier Univ Hosp, Dept Med Pharmacol & Toxicol, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-058
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [31] TNF-α inhibitors as therapy for drug-induced severe cutaneous adverse reactions: a case series
    Chu, Yanjun
    Xu, Mengjun
    Dong, Xiaoqing
    Zhou, Jiong
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [32] Hyponatraemia as an Adverse Drug Reaction of Antipsychotic Drugs A Case-Control Study in VigiBase
    Mannesse, Cyndie K.
    van Puijenbroek, Eugene P.
    Jansen, Paul A. F.
    van Marum, Rob J.
    Souverein, Patrick C.
    Egberts, Toine C. G.
    DRUG SAFETY, 2010, 33 (07) : 569 - 578
  • [33] OLIGOCLONAL LYMPHOCYTOSIS ASSOCIATED WITH ELEVATED IL6 AND IL10 IN A CASE OF SEVERE CUTANEOUS ADVERSE DRUG REACTION
    Jeelall, Yogesh
    Singh, Manu
    Lai, Jeffrey
    Ali, Syed
    Jackson, Katherine
    Hollingsworth, Peter N.
    de Boer, Bastiaan
    Wood, Benjamin
    Reed, Joanne
    Goodnow, Christopher
    Mclean-Tooke, Andrew
    Lucas, Michaela
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 28 - 29
  • [34] A real-world pharmacovigilance study of severe cutaneous adverse reactions associated with antiepileptic drug combination therapy: data mining of FDA adverse event reporting system
    Wei, Chunyan
    Zhang, Jingyi
    Yin, Wanhong
    Jiang, Aidou
    Liu, Yin
    Wu, Bin
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (06) : 509 - 515
  • [35] Severe adverse cutaneous reactions induced by gefitinib combined with antihypertensive and antihyperlipidemic drugs in lung cancer: a case report
    Shen, Xiao
    Fan, Guorong
    Liu, Gaolin
    Wang, Fan
    Li, Qi
    Liu, Xinyan
    Zhu, Hong
    Zhu, Ying
    Lu, Jiguang
    Wang, Shuowen
    ANTI-CANCER DRUGS, 2022, 33 (01) : E802 - E807
  • [36] Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase®)
    Dernoncourt, A.
    Liabeuf, S.
    Bennis, Y.
    Masmoudi, K.
    Gras-Champel, V.
    Batteux, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 32 - 32
  • [37] SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database
    Moumouni, Abdel Nasser Ado
    Robin, Perrine
    Hillaire-Buys, Dominique
    Faillie, Jean-Luc
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 (02) : 216 - 226
  • [38] Interstitial lung disease associated with immune checkpoint inhibitors: Disproportionality analysis using the World Health Organization's adverse drug reactions database
    Palassin, P.
    Ladhari, C.
    Maria, A.
    Quantin, X.
    Hillaire-Buys, D.
    Guilpain, P.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 136 - 136
  • [39] A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis
    Noordally, Sheik Oaleed
    Sohawon, Schoeb
    Vanderhulst, Julien
    Duttmann, Ruth
    Corazza, Francis
    Devriendt, Jacques
    ANNALS OF SAUDI MEDICINE, 2012, 32 (03) : 309 - 311
  • [40] A case of Telaprevir-associated severe cutaneous adverse reaction: evidence of immune-mediated mechanism
    Aitella, E.
    Abbondanza, C.
    Federico, A.
    Pezone, L.
    Savoia, A.
    De Bartolomeis, F.
    Sacerdoti, C.
    Masotta, T.
    Di Sarno, S.
    Astarita, C.
    ALLERGY, 2014, 69 : 377 - 377
12345